TRV-2026-2893Version 1 · Published

Saved · see the current record

Why this version exists

Certified into the record

The exact text we saved

This is the version exactly as it was saved, character for character. The SHA-256 hash below is a 64-character code worked out from that text. Run the same text through SHA-256 and you get the same code; change a single letter and the code comes out completely different. Each version also stores the previous version’s hash, which chains them together so no version can be swapped out quietly.

TRUVACE RECORD VERSION
record: TRV-2026-2893
version: 1
kind: certified
reason: Certified into the record
timestamp: 2026-11-13T18:01:58.043057Z
status: published
lens: g_space
sector: health
headline: Can radiomics outperform radiologists in predicting Ewing sarcoma response to neoadjuvant chemotherapy from longitudinal MRI?
dek: This retrospective, multicenter study evaluated whether MRI-based radiomics can predict the histological response to neoadjuvant chemotherapy in Ewing sarcoma patients and compared their performance to that of radiological findings. Definitive histological assessment is only possible during surgery, potentially delaying therapy changes and increasing metastatic risk; therefore, a positive outcome would enable early adaptations. Radiomics features were extracted from pre- and post-neoadjuvant (after first chemoth…
gain_title: In a retrospective study of 96 Ewing sarcoma patients, MRI radiomics models identified chemotherapy responders with an AUROC of 0.62, above 0.58 for the best model built on radiologist readings and 0.53 for a clinical baseline.
problem_title: (none)
trace_subject: (none)
gain_reading: In a retrospective study of 96 Ewing sarcoma patients, MRI radiomics models identified chemotherapy responders with an AUROC of 0.62, above 0.58 for the best model built on radiologist readings and 0.53 for a clinical baseline.
gain_evidence: surpassing the best radiological model, which relied on the relative change in maximum diameter of extratumoral soft tissue components (AUROC, 0.58; 95% CI: 0.56, 0.60)
problem_reading: (none)
problem_evidence: (none)
quick_read: A retrospective multicenter study of 96 people with Ewing sarcoma, a bone and soft-tissue cancer, tested whether machine learning on MRI scans can predict how well tumours respond to chemotherapy. The best radiomics model, built on changes in T1 fat-saturated contrast-enhanced images, reached an AUROC of 0.62, against 0.58 for the best model based on radiologist readings.

Definitive response can only be judged from tissue after surgery, which can delay changes to treatment and may raise metastatic risk. An earlier prediction from scans could allow therapy to be adapted sooner. The authors describe the identification of responders as moderate and the findings as exploratory, complementary to standard size-based assessment, and call for larger prospective trials.
limitation: The study was retrospective and exploratory, the identification of responders was only moderate, and the authors say larger prospective trials are needed to validate the findings.
tag: Evidence-backed gain
key_points: The study included 96 patients (mean age 19.9 ± 11.7 years; 41 women) treated for Ewing sarcoma between 2004 and 2020. | Radiomics features were taken from scans before chemotherapy and after the first chemotherapy cycle. | Four machine learning models were trained with nested cross-validation to predict histological response. | The best radiomics model scored an AUROC of 0.62 (95% CI 0.59 to 0.65), using low gray level intensity changes in T1 fat-saturated contrast-enhanced sequences. | The best radiologist-feature model, based on change in maximum diameter of extratumoral soft tissue components, scored 0.58 (95% CI 0.56 to 0.60). | Radiomics models using only pre-treatment T2-weighted data scored 0.61, against 0.53 for the clinical baseline.
rundown: Researchers extracted radiomics features from MRI scans taken before neoadjuvant chemotherapy and after the first cycle in patients treated from 2004 to 2020 at multiple centers. They compared four machine learning models with models trained on semantic features from expert radiological readings, measuring performance by AUROC.

The top radiomics model used low gray level intensity changes in contrast-enhanced T1 fat-saturated scans and scored 0.62. The best radiological model relied on the relative change in maximum diameter of extratumoral soft tissue components and scored 0.58. Pre-treatment T2-weighted radiomics scored 0.61, while the clinical baseline scored 0.53.

The authors say radiomics may capture non-size tissue signals that could guide personalized treatment adaptations and reduce delays for non-responders. They describe the findings as exploratory and say larger studies within a multimodal framework are needed to validate them.
sources:
- peer_reviewed | BMC Cancer | https://doi.org/10.1186/s12885-026-17332-0 | 2026-11-12
prev: 0000000000000000000000000000000000000000000000000000000000000000
SHA-256 hash
1b71cfcba5b2ea916a0623b497c4f877833a802ab36fd74039f33edeed68ec4b
Previous version’s hash
0000000000000000000000000000000000000000000000000000000000000000
Check this record hasn’t been altered
How to check it yourself, without trusting this page

Download any version from /api/record/TRV-2026-2893 and hash its canonical field yourself, for example with shasum -a 256. You should get its content_hash. Each version’s text also ends with prev:and the hash of the version before it (version 1 points to 64 zeros). If anyone had changed a single character of any version after it was saved, those hashes wouldn’t line up.